The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((1H-1,2,4-triazol-1-yl)methyl)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)-4-phenyl-4,5-dihydrooxazole ID: ALA4877761
PubChem CID: 164628953
Max Phase: Preclinical
Molecular Formula: C24H19FN4O
Molecular Weight: 398.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Fc1cc(C2=NC(Cn3cncn3)(c3ccccc3)CO2)ccc1-c1ccccc1
Standard InChI: InChI=1S/C24H19FN4O/c25-22-13-19(11-12-21(22)18-7-3-1-4-8-18)23-28-24(15-30-23,14-29-17-26-16-27-29)20-9-5-2-6-10-20/h1-13,16-17H,14-15H2
Standard InChI Key: VJURDMMDZCHZKM-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
13.6818 -10.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1259 -8.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3961 -7.8986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7096 -8.3427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5545 -8.0341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2120 -6.7711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1666 -9.0905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7485 -9.1637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5177 -7.2136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2852 -8.4133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9395 -7.1468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9800 -7.9658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4756 -9.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8966 -11.7294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9132 -9.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9106 -12.6195 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2315 -12.4802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8963 -10.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3069 -11.0226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0810 -11.8164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6217 -13.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2285 -9.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0833 -10.2222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6211 -9.0139 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2609 -10.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0457 -10.4497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2516 -9.6604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6664 -9.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8838 -9.3064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3535 -7.0747 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
11 6 1 0
4 8 2 0
8 13 1 0
13 7 2 0
3 4 1 0
10 12 1 0
6 9 2 0
12 4 1 0
5 10 2 0
7 2 1 0
9 5 1 0
12 11 2 0
24 15 1 0
21 17 2 0
20 16 2 0
15 23 2 0
23 18 1 0
18 19 1 0
17 14 1 0
18 22 1 0
14 20 1 0
22 24 1 0
16 21 1 0
18 1 1 0
19 14 1 0
15 7 1 0
1 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 1 1 0
3 30 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.44Molecular Weight (Monoisotopic): 398.1543AlogP: 4.46#Rotatable Bonds: 5Polar Surface Area: 52.30Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.38CX LogP: 4.85CX LogD: 4.85Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.50Np Likeness Score: -0.74
References 1. Zhao L, Yin W, Sun Y, Sun N, Tian L, Zheng Y, Zhang C, Zhao S, Su X, Zhao D, Cheng M.. (2021) Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: Design, synthesis, and structure-activity relationship studies of dihydrooxazole derivatives., 224 [PMID:34364163 ] [10.1016/j.ejmech.2021.113715 ]